V. Kaplunova

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy

F. M. Bogatyreva, V. Kaplunova, M. Kozhevnikova, 2022, Cardiovascular Therapy and Prevention.

[Analysis of morpho-functional parameters of the heart and polymorphisms of Renin-Angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy].

V. Kaplunova, E. Privalova, Y. Belenkov, 2010, Kardiologiia.

Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy

F. M. Bogatyreva, V. Kaplunova, M. Kozhevnikova, 2021, Rational Pharmacotherapy in Cardiology.

[Hypertrophic Cardiomyopathy and Ischemic Heart Disease. Variants of Combination Pathology].

V. Kaplunova, M. Kozhevnikova, G. Shakaryants, 2017, Kardiologiia.

2020 Clinical practice guidelines for Hypertrophic cardiomyopathy

A. Kostareva, O. Stukalova, O. Irtyuga, 2021, Russian Journal of Cardiology.

[Modern approaches to the problem of hypertrophic cardiomyopathy].

V. Kaplunova, M. Kozhevnikova, E. Privalova, 2016, Klinicheskaia meditsina.

Hypertrophiccardiomyopathy: forms and variants of the course, approaches to pharmacotherapy.

V. Kaplunova, M. Kozhevnikova, G. Shakaryants, 2018 .

Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria

V. Kaplunova, M. Kozhevnikova, G. Shakaryants, 2018, Rational Pharmacotherapy in Cardiology.